Comment: Lacosamide for the Treatment of Refractory Status Epilepticus

Fernandez EM , Franck AJ . Lacosamide for the treatment of refractory status epilepticus. Ann Pharmacother 2011; 45:1445–9. DOI 10.1345/aph.1Q461

Shorvon S , Ferlisi M . The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain 2011; 134(Pt 10):2802–18.

Shorvon S , Baulac M , Cross H , Trinka E , Walker M ; TaskForce on Status Epilepticus of the ILAE Commission for European Affairs. The drug treatment of status epilepticus in Europe: consensus document from a workshop at the first London Colloquium on Status Epilepticus. Epilepsia 2008; 49:1277–85.

Treiman DM , Meyers PD , Walton NY . A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998; 339:792–8.

Alldredge BK , Gelb AM , Isaacs SM . A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 2001; 345:631–7. Erratum in: N Engl J Med 2001; 345:1860.

Leppik IE , Derivan AT , Homan RW , Walker J , Ramsay RE , Patrick B . Double-blind study of lorazepam and diazepam in status epilepticus. JAMA 1983; 249:1452–4.

Prasad K , Al-Roomi K , Krishnan PR , Sequeira R . Anticonvulsant therapy for status epilepticus. Cochrane Database Syst Rev 2005; (4):CD003723.

Parkerson KA , Reinsberger C , Chou SH , Dworetzky BA , Lee JW . Lacosamide in the treatment of acute recurrent seizures and periodic epileptiform patterns in critically ill patients. Epilepsy Behav 2011; 20:48–51.

LaRoche SM , Shivdat-Nanhoe R . Subacute encephalopathy and seizures in alcoholics (SESA) presenting with non-convulsive status epilepticus. Seizure 2011; 20:505–8.

Granda-Méndez J , Toledo M , Flores-Flores A , Santamarina E , Sarria S , Salas-Puig J . Intravenous lacosamide in monotherapy in a case of complex partial epileptic status. Rev Neurol 2011; 53:61–3.

Torres-Cano N , Giner Bayarri P , Chilet-Chilet MR . Refractory non-convulsive status epilepticus. Rev Neurol 2011; 53:255–6.

Cherry S , Judd L , Muniz JC , Elzawahry H , Laroche S . Safety and efficacy of lacosamide in the intensive care unit. Neurocrit Care 2012; 16:294–8.

Kellinghaus C , Berning S , Besselmann M . Intravenous lacosamide as successful treatment for nonconvulsive status epilepticus after failure of first-line therapy. Epilepsy Behav 2009; 14:429–31.

Tilz C , Resch R , Hofer T , Eggers C . Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide. Epilepsia 2010; 51:316–7.

Kellinghaus C , Berning S , Immisch I . Intravenous lacosamide for treatment of status epilepticus. Acta Neurol Scand 2011; 123:137–41. DOI 10.1111/j.1600-0404.2010.01423.x

Höfler J , Unterberger I , Dobesberger J , Kuchukhidze G , Walser G , Trinka E . Intravenous lacosamide in status epilepticus and seizure clusters. Epilepsia 2011; 52:e148–52. DOI 10.1111/j.1528-11672011.03204 a

Albers JM , Moddel G , Dittrich R . Intravenous lacosamide–an effective add-on treatment of refractory status epilepticus. Seizure 2011; 20:428–30.

Rantsch K , Walter U , Wittstock M , Benecke R , Rösche J . Efficacy of intravenous lacosamide in refractory nonconvulsive status epilepticus and simple partial status epilepticus. Seizure 2011; 20:529–32.

Cerebyx (fosphenytoin sodium) injection. MedWatch. The FDA Safety Information and Adverse Event Reporting Program, http://www.ida.gov/Safety/MedWatch/SafetyInformation/ucm283239.htm (accessed 2011 Nov).